HONG KONG, Feb. 17, 2014 /PRNewswire-FirstCall/ -- China
Cord Blood Corporation (NYSE: CO) (the "Company") today announced
its plan to release financial results for the third quarter and
first nine months of fiscal year 2014 on Monday, February 24, 2014, after the markets
close in the U.S.
The Company will host a conference call at 8:00 a.m. ET on Tuesday,
February 25, 2014 to discuss its financial performance and
give a brief overview of the Company's recent developments,
followed by a question and answer session. Interested parties may
access the audio webcast through the Company's IR website at
http://ir.chinacordbloodcorp.com. A replay of the webcast will be
accessible two hours after the conference call and available for
three weeks at the same URL link above. Listeners may also access
the call by dialing 1-631-514-2526 or 1-855-298-3404 for US callers
or +852-5808-3202 for Hong Kong
callers, access code: 2926250.
Please dial in ten minutes prior to the conference call to
ensure proper connection, and be prepared to provide your name and
company name to the operator.
Supplemental financial information referenced in the conference
call and the third quarter of fiscal 2014 earnings press release
will be available at http://www.chinacordbloodcorp.com, in the
section titled Investor Center/Press Release, after 4:00 p.m. ET on Monday,
February 24, 2014 and in the Company's Report on Form 6-K
for the month of February 2014
available on the Securities and Exchange Commission's website at
www.sec.gov.
About China Cord Blood Corporation
China Cord Blood Corporation is the first and largest umbilical
cord blood banking operator in China in terms of geographical coverage and
the only cord blood banking operator with multiple licenses. Under
current PRC government regulations, only one licensed cord blood
banking operator is permitted to operate in each licensed region
and only seven licenses have been authorized as of today. China
Cord Blood Corporation provides cord blood collection, laboratory
testing, hematopoietic stem cell processing and stem cell storage
services. For more information, please visit the Company's website
at http://www.chinacordbloodcorp.com.
For more information, please contact:
China Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Email: ir@chinacordbloodcorp.com
ICR, Inc.
Mr. William Zima
Tel: (+86) 10-6583-7511
U.S. Tel: (646) 405-5185
Email: william.zima@icrinc.com
SOURCE China Cord Blood Corporation